Carmel Shachar, JD, MPH and Dorit Rubinstein Reiss, LLB, PhD
Legal approaches to preserving social stability, maintaining trust, supporting therapeutic research opportunities, or diminishing disease severity deserve ethical scrutiny.
AMA J Ethics. 2020;22(1):E36-42. doi:
10.1001/amajethics.2020.36.
Being close enough to patients to care is as critical as remaining distant enough from a pathogen to be safe. This strategy simultaneously frustrates and supports public trust.
AMA J Ethics. 2020;22(1):E22-27. doi:
10.1001/amajethics.2020.22.
How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”?
AMA J Ethics. 2020;22(1):E43-49. doi:
10.1001/amajethics.2020.43.
Madeline J. Hooper joins Ethics Talk to discuss her article, coauthored with Lauren C. Linkowski, Dr Lynette Menezes, and Dr Jordan Messler: "Summer Without Shelter in Tampa During COVID-19."
Streamlining US health care business has raised unique privacy concerns. Bills and explanations of benefits contain protected health information that could be disclosed to someone other than the patient.
AMA J Ethics. 2016;18(3):279-287. doi:
10.1001/journalofethics.2016.18.3.pfor4-1603.
Mary Anderlik Majumder, JD, PhD and Christi J. Guerrini, JD
Amendments to the Common Rule and Health Insurance Portability and Accountability Act (HIPAA) raise questions about broad consent and sale of health data.
AMA J Ethics. 2016;18(3):288-298. doi:
10.1001/journalofethics.2016.18.3.pfor5-1603.